Finding Potent Inhibitors Against SARS-CoV-2 Main Protease Through Virtual Screening, ADMET, and Molecular Dynamic Simulation Studies (original) (raw)

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors

Computational Biology and Chemistry, 2020

Structure-based identification of potential SARS-CoV-2 main protease inhibitors

Dr. Aqib Iqbal, Professor, Department of Agronomy

Journal of Biomolecular Structure and Dynamics, 2020

Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2

Dheeraj Chaurasia

Journal of Biomolecular Structure and Dynamics

View PDFchevron_right

Novel Inhibitors of the Main Protease of SARS-CoV-2 Identified via a Molecular Dynamics Simulation-Guided in Vitro Assay

Monika Coronado

View PDFchevron_right

Computational Discovery of Small Drug-like Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease

Alexander Tuzikov

View PDFchevron_right

Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening

Salvatore Di Maro

Journal of Chemical Information and Modeling

View PDFchevron_right

Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (Mpro) through docking, molecular mechanic dynamic, and ADMET profiling

Wojciech Kolodziejczyk

Journal of Biomolecular Structure and Dynamics

View PDFchevron_right

Virtual Screening of Potential Inhibitors for SARS-CoV-2 Main Protease

Carlos Javier Alméciga Díaz

View PDFchevron_right

Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mpro): DFT, QSAR, molecular docking, and in silico toxicity analysis

Lucia Pintilie

Journal of King Saud University - Science, 2021

View PDFchevron_right

Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study

Md. Arif Khan

Journal of Biomolecular Structure and Dynamics, 2020

View PDFchevron_right

Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases

Rupal Ojha

Journal of Biomolecular Structure & Dynamics, 2020

View PDFchevron_right

Initial study on SARS-CoV-2 main protease inhibition mechanism of some potential drugs using molecular docking simulation

toan tran quoc

Vietnam Journal of Science and Technology, 2020

View PDFchevron_right

Structure-based Virtual Screening and Molecular Dynamic Simulation Studies of the Natural Inhibitors of SARS-CoV-2 Main Protease

adekunle rowaiye

2020

View PDFchevron_right

Modelling of potentially promising SARS protease inhibitors

Dariusz Plewczynski

Journal of Physics: Condensed Matter, 2007

View PDFchevron_right

Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking

Vladislav Naumovich

2020

View PDFchevron_right

In Silico Screening of Potential Antiviral Inhibitors against SARS-CoV-2 Main Protease

K Rudharachari Maiyelvaganan

View PDFchevron_right

Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2

Karolina Mitusinska

International Journal of Molecular Sciences, 2021

View PDFchevron_right

The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation

Mohammad Ghattas

Molecules

View PDFchevron_right

A student led computational screening of peptide inhibitors against main protease of SARS‐CoV ‐2

Pranto Saha

Biochemistry and Molecular Biology Education

View PDFchevron_right

Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach

Ashwil Klein

Journal of Biomolecular Structure and Dynamics

View PDFchevron_right

High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2

maryam olagunju

2020

View PDFchevron_right

Computational Screening for Potential Drug Candidates Against SARS-CoV-2 Main Protease

Andria Freitas

2020

View PDFchevron_right

Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies

PREM KUSHWAHA

Journal of Biomolecular Structure and Dynamics

View PDFchevron_right

In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing

Reetikesh Patel

Journal of Infection and Public Health, 2020

View PDFchevron_right

Discovery of a Novel Family of SARS-CoV Protease Inhibitors by Virtual Screening and 3D-QSAR Studies

Neeraj Mahindroo

Journal of Medicinal Chemistry, 2006

View PDFchevron_right

Finding Potent Inhibitors Against SARS-CoV-2 Main Protease Through Virtual Screening, ADMET, and Molecular Dynamic Simulation Studies (original) (raw)

Related papers